Nadia Dandachi

11PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markersLiquid biopsiesDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 21, 2026
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.

Deepti Agrawal, Katarina Cisarova, Sebastian Vosberg

|Jan 22, 2025
Circulating tumor DNA (ctDNA) trajectories predict survival in trifluridine/tipiracil-treated metastatic colorectal cancer patients.

Matthias Unseld, Stefan Kühberger, Ricarda Graf

|Jan 08, 2023
Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression.

Iva Brcic, Andrea Maria Kluba, Theresa Marie Godschachner

|Nov 10, 2021
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.

Christoph Suppan, Ricarda Graf, Stephan Jahn

|Jul 02, 2021
Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study.

Marina Berger, Andrea Thueringer, Doritt Franz

|Jun 02, 2021
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.

Noemi Laprovitera, Mattia Riefolo, Elisa Porcellini

Pageof 2

Frequent Collaborators

5 joint publications

Marija Balic

3 joint publications

Ellen Heitzer

2 joint publications

Iva Brcic

2 joint publications

Martin Pichler